These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 22889778)
1. Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT. Calabria F; Schillaci O Clin Nucl Med; 2012 Sep; 37(9):878-9. PubMed ID: 22889778 [TBL] [Abstract][Full Text] [Related]
2. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer. Kauhanen S; Schalin-Jäntti C; Seppänen M; Kajander S; Virtanen S; Schildt J; Lisinen I; Ahonen A; Heiskanen I; Väisänen M; Arola J; Korsoff P; Ebeling T; Sane T; Minn H; Välimäki MJ; Nuutila P J Nucl Med; 2011 Dec; 52(12):1855-63. PubMed ID: 22052128 [TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma. Verbeek HH; Plukker JT; Koopmans KP; de Groot JW; Hofstra RM; Muller Kobold AC; van der Horst-Schrivers AN; Brouwers AH; Links TP J Nucl Med; 2012 Dec; 53(12):1863-71. PubMed ID: 23081996 [TBL] [Abstract][Full Text] [Related]
4. Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging. Marzola MC; Pelizzo MR; Ferdeghini M; Toniato A; Massaro A; Ambrosini V; Fanti S; Gross MD; Al-Nahhas A; Rubello D Eur J Surg Oncol; 2010 Apr; 36(4):414-21. PubMed ID: 20100647 [TBL] [Abstract][Full Text] [Related]
5. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET demonstrates crossed cerebellar diaschisis 20 years after stroke. Shih WJ; Huang WS; Milan PP Clin Nucl Med; 2006 May; 31(5):259-61. PubMed ID: 16622331 [TBL] [Abstract][Full Text] [Related]
7. F-Dopa as an amino acid tracer to detect brain tumors. Heiss WD; Wienhard K; Wagner R; Lanfermann H; Thiel A; Herholz K; Pietrzyk U J Nucl Med; 1996 Jul; 37(7):1180-2. PubMed ID: 8965194 [TBL] [Abstract][Full Text] [Related]
8. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Li DL; Xu YK; Wang QS; Wu HB; Li HS Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis. Segtnan EA; Grupe P; Jarden JO; Gerke O; Ivanidze J; Christlieb SB; Constantinescu C; Pedersen JE; Houshmand S; Hess S; Zarei M; Gjedde A; Alavi A; Høilund-Carlsen PF J Nucl Med; 2017 May; 58(5):768-773. PubMed ID: 27789719 [TBL] [Abstract][Full Text] [Related]
10. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy]. Chen YR; Li WX; Lin YR; Chen LH Ai Zheng; 2004 Oct; 23(10):1210-2. PubMed ID: 15473938 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]